Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA)

Biochem Pharmacol. 1984 Jun 15;33(12):1831-8. doi: 10.1016/0006-2952(84)90536-7.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Coronary Disease / drug therapy*
  • Fibrinolysin / antagonists & inhibitors
  • Fibrinolysin / physiology
  • Fibrinolysis / drug effects*
  • Humans
  • Plasminogen / physiology
  • Plasminogen Activators / metabolism
  • Plasminogen Activators / pharmacology
  • Plasminogen Activators / therapeutic use*
  • Streptokinase / pharmacology
  • Urokinase-Type Plasminogen Activator / pharmacology

Substances

  • Plasminogen
  • Streptokinase
  • Plasminogen Activators
  • Fibrinolysin
  • Urokinase-Type Plasminogen Activator